China Has Detained Senior AstraZeneca Executive A senior AstraZeneca executive is under detention by Chinese authorities investigating the U.K. pharmaceutical company's employees in the country. Leon ...

Current health news highlights the expected high demand for Novo Nordisk's obesity drug in India, the need for personalized approaches in knee replacement surgeries, Gilead's notable financial ...

Faster diagnostics, more targeted treatment and better communication are among areas of healthcare already benefiting from artificial intelligence ...

Scientists have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

Quantum computing company IonQ (NYSE: IONQ) today announced financial results for the quarter ended September 30, 2024. “We ...

CVS Health's new chief executive, David Joyner named former UnitedHealth Group executive Steve Nelson as head of Aetna, CVS's troubled insurance unit. A senior AstraZeneca executive is under detention ...

The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. Antibody drug conjugates ...

IonQ Inc reports third-quarter financial results after the market close on Wednesday. Here's everything you need to know from ...

Key Takeaways Zacks earnings estimates for AstraZeneca are currently at $4.06 per share. However, the earnings picture ...

Based on early Phase I/II trial data, Tango has decided to end enrollment in a study of TNG908 and focus resources on more promising drugs in its pipeline.